Replies to post #308838 on Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

LINK TO ACTUAL TRIAL DATA WHERE A2-73 SHOWED "EXCELLENT RESULTS IN INCREASING REM SLEEP"????????

A2-73 showed excellent results in increasing REM sleep while Fluvoxamine causes insomnia.

GOOD LUCK AND GOD BLESS!!!!!!

[tredenwater2]

Great points again! Absolutely amazing!

[Investor2014]

Was that a fully verified and double biochecked post or one written half asleep?

See below and let me know.

https://www.dovepress.com/the-effect-of-fluvoxamine-on-sleep-architecture-of-depressed-patients--peer-reviewed-fulltext-article-NSS


“Results: Compared with baseline, the percentage of stage 3 sleep had significantly (F=11.630, P=0.001) increased in all 3 visits. Moreover, the percentage of rapid eye movement sleep was reduced during the study, with only a significant difference (F=3.991, P=0.027) between baseline and day 14. Finally, 47.8% (11/23) of the participants were in remission, and 60.9% (14/23) of them did not report insomnia. The clinical remission ratio of the persistent insomnia group (11.1% [1/9]) (?2=8.811, P=0.004) was significantly lower than that of the non-insomnia group (71.4% [10/14]) at the endpoint. Additionally, during the first clinical evaluation (day 14), patients without insomnia had significantly higher final remission ratios than patients with insomnia (80% [8/10] versus 30.8% [4/13]; ?2=5.79; P=0.016).
Conclusion: Fluvoxamine improved PSG parameters and ameliorated complaints of insomnia simultaneously during this 8-week study. Moreover, depressed individuals who reported persistent insomnia were at higher risk of remaining depressed by the end of the trial, which might be forecasted by the sleep status on day 14.”

[Irishmick8299]

Dr M has to have data by now. What’s the holdup? It’s high time for him to deliver!